Revisiting induction chemotherapy before radiotherapy for head and neck cancer, part I: carcinoma of non-nasopharyngeal sites

Christopher H Chapman; Upendra Parvathaneni; Sue S Yom

doi:10.2217/fon-2016-0502

Revisiting induction chemotherapy before radiotherapy for head and neck cancer, part I: carcinoma of non-nasopharyngeal sites

Future Oncol. 2017 Mar;13(6):469-475. doi: 10.2217/fon-2016-0502.

Authors

Christopher H Chapman¹, Upendra Parvathaneni², Sue S Yom¹

Affiliations

¹ Department of Radiation Oncology, University of California San Francisco, CA, USA.
² Department of Radiation Oncology, University of Washington, WA, USA.

PMID: 28169592
DOI: 10.2217/fon-2016-0502

No abstract available

Keywords: antineoplastic agents; antineoplastic combined chemotherapy protocols; carcinoma; chemotherapy; clinical trials; combined modality therapy; head and neck neoplasms; induction therapy; molecular-targeted therapy; neoadjuvant therapy; sequential therapy; squamous cell; treatment outcomes.

Publication types

Review

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Bridged-Ring Compounds / administration & dosage
Combined Modality Therapy
Head and Neck Neoplasms / drug therapy*
Head and Neck Neoplasms / pathology
Head and Neck Neoplasms / radiotherapy
Humans
Induction Chemotherapy
Neoplasm Metastasis
Organ Sparing Treatments
Radiotherapy, Intensity-Modulated / methods
Taxoids / administration & dosage
Treatment Outcome

Substances

Bridged-Ring Compounds
Taxoids
taxane